Vericel Corporation (VCEL) Price Target Analysis
Wall Street analyst price targets, ratings consensus & upside potential · Updated May 1, 2026
Current Price
$35.13
Price Target
$44.00
Target Range
$42.00 — $46.00
Analyst Rating
Buy
Forward P/E80.9x
Trailing P/E109.8x
Forward PEG2.05
Implied Growth+37.0%
Median Target$44.00
Analyst Spread9.1%
Price Forecast (1 Year)
Last 12 months price action with 12-month analyst target path
Bear Case
$42
+19.6%
Consensus
$44
+25.2%
Bull Case
$46
+30.9%
VCEL Price Target Analysis
Updated May 8, 2026As of May 8, 2026, Vericel Corporation (VCEL) has a Wall Street consensus price target of $44.00, based on estimates from 14 covering analysts. With the stock currently trading at $35.13, this represents a potential upside of +25.2%. The company has a market capitalization of $1.79B.
Analyst price targets range from a low of $42.00 to a high of $46.00, representing a 9% spread in expectations. The median target of $44.00 aligns closely with the consensus average. The tight target dispersion indicates high conviction among analysts.
The current analyst consensus rating is Buy, with 9 analysts rating the stock as a Buy or Strong Buy,5 rating it Hold, and 0 rating it Sell or Strong Sell. The positive sentiment balance indicates moderate optimism about the stock prospects.
From a valuation perspective, VCEL trades at a trailing P/E of 109.8x and forward P/E of 80.9x. The forward PEG ratio of 2.05 reflects a premium valuation. Analysts expect EPS to grow +37.0% over the next year.
Investment Context: Price targets represent analyst expectations for the next 12 months and should be considered alongside your own research. Targets are based on analysts' assumptions about earnings growth, margins, and market conditions which may change. For sector-specific context, view other Healthcare stocks.
Analyst Sentiment Comparison
Industry Peer AnalysisAvg Peer Upside+1017.1%
Avg Forward P/E295.2x
Peers with Coverage9 / 10
| Company | Market Cap | Price | Target | Upside | Rating | Fwd P/E | Analysts |
|---|---|---|---|---|---|---|---|
 MGTXMeiraGTx Holdings plc | $779M | $9.68 | $23.33 | +141.0% | Buy | — | 6 |
 RCKTRocket Pharmaceuticals, Inc. | $398M | $3.67 | $5.00 | +36.2% | Buy | — | 19 |
 FATEFate Therapeutics, Inc. | $280M | $2.43 | $39.50 | +1525.5% | Buy | — | 31 |
 AGIOAgios Pharmaceuticals, Inc. | $1.6B | $27.53 | $37.75 | +37.1% | Buy | — | 29 |
 NTLAIntellia Therapeutics, Inc. | $1.6B | $13.71 | $20.88 | +52.3% | Buy | — | 39 |
 SGMOSangamo Therapeutics, Inc. | $22M | $0.10 | $7.25 | +7064.0% | Hold | — | 14 |
 MDXGMiMedx Group, Inc. | $548M | $3.69 | $10.00 | +171.0% | Buy | 295.2x | 15 |
 TELATELA Bio, Inc. | $44M | $1.10 | — | — | — | — | — |
 NVCRNovoCure Limited | $1.9B | $16.83 | $33.50 | +99.0% | Buy | — | 15 |
 OSUROraSure Technologies, Inc. | $225M | $3.13 | $4.00 | +27.8% | Hold | — | 13 |
Upside Potential Comparison
SGMOFATEMDXGMGTXNVCRNTLAAGIORCKTSee VCEL's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs VCEL Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare VCEL vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonVCEL — Frequently Asked Questions
Quick answers to the most common questions about buying VCEL stock.
What is the VCEL stock price target for 2026?
The consensus Wall Street price target for VCEL is $44, representing 25.2% upside from the current price of $35.13. With 14 analysts covering the stock, this strong upside suggests significant value not yet reflected in today's share price.
Is VCEL a buy, sell, or hold?
VCEL has a consensus rating of "Buy" based on 14 Wall Street analysts. The rating breakdown is predominantly bullish, with 9 Buy/Strong Buy ratings. The consensus 12-month price target of $44 implies 25.2% upside from current levels.
Is VCEL stock overvalued or undervalued?
At a forward P/E of 80.8516x, VCEL trades at a premium valuation. The consensus price target of $44 (25.2% upside) suggests analysts still see growth justifying the multiple.
How high can VCEL stock go?
The most bullish Wall Street analyst has a price target of $46 for VCEL, while the most conservative target is $42. The consensus of $44 represents the median expectation. These targets typically reflect 12-month expectations.
How many analysts cover VCEL stock?
VCEL is moderately covered, with 14 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 9 have Buy ratings, 5 recommend Hold, and 0 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
What is the VCEL stock forecast?
The 12-month VCEL stock forecast based on 14 Wall Street analysts shows a consensus price target of $44, with estimates ranging from $42 (bear case) to $46 (bull case). The median consensus rating is "Buy".
What is VCEL's forward P/E ratio?
VCEL trades at a forward P/E ratio of 80.9x based on next-twelve-months earnings estimates compared to a trailing P/E of 109.8x. The lower forward P/E indicates analysts expect earnings growth. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.
Should I buy VCEL stock?
Wall Street analysts are very optimistic on VCEL, with a "Buy" consensus rating and $44 price target (25.2% upside). 9 of 14 analysts rate it Buy or Strong Buy. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
Why do VCEL price targets vary so much?
VCEL analyst price targets range from $42 to $46, a 9% tight range reflecting strong analyst consensus. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $44 consensus represents the middle ground.